Delivery Order SPE2DB20D3103-SPE2DB24FQ1K2

Award Date 9/3/24
Potential Completion Date 9/24/24
Potential Value $6.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $9,085.44 firm fixed-price contract is for the supply of 4567104870 - YONSA 125 MG TABLET 120S, with a completion date of February 21, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, serving as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,195.48, is a delivery order for the supply of 4,566,374,320 units of the pharmaceutical product YONSA 125 MG TABLET 120S. The contract has a firm fixed price pricing type and an ultimate completion date of December 2, 2024. Amerisourcebergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,390.96 firm fixed-price delivery order is for the provision of 4565912317 - YONSA 125 MG TABLET 120S, with a period of performance through October 15, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,195.48 firm fixed-price delivery order is for the supply of Yonsa 125 mg tablets. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC serves as the primary vehicle for...
This federal contract award, valued at $2,271.36, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies, including...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,271.36 firm fixed-price delivery order is for the supply of YONSA 125 MG TABLET 120S, a pharmaceutical product. The contract has an ultimate completion date of December 18, 2024 and was awarded on November 26, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) is for the delivery of the pharmaceutical product YONSA 125 MG TABLET 120S. The award, valued at $2,195.48, is a Firm Fixed Price Delivery Order with an ultimate completion date of April 19, 2024. The contract is not designated as a set-aside. As a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, Amerisourcebergen holds...
This federal contract award, valued at $6,814.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of YONSA 125 MG TABLET 120S, a pharmaceutical product, with an ultimate completion date of January 14, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,271.36 firm fixed-price delivery order is for the supply of YONSA 125 MG TABLET 120S, a pharmaceutical product. The contract has an ultimate completion date of June 26, 2025 and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order worth $2,195.48 to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FQ1K2
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,586.44 firm fixed-price delivery order is for the supply of 4565666593 YONSA 125 MG TABLET 120S, with a period of performance through September 24, 2024.

AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

The contract award did not utilize any set-aside designations, indicating open competition. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems.

Generated 2/27/25, 11:01 AM